David Loomis
Comptroller/Controller/Auditor chez ARVINAS, INC.
Fortune : 268 600 $ au 30/04/2024
Profil
David Loomis is currently the Chief Accounting Officer & VP-Corporate Controller at Arvinas, Inc. Prior to his current position, he worked as a Controller at Biohaven Pharmaceutical Holding Co. Ltd.
and Biohaven Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARVINAS, INC.
0,01% | 23/02/2024 | 8 500 ( 0,01% ) | 268 600 $ | 30/04/2024 |
Postes actifs de David Loomis
| Sociétés | Poste | Début |
|---|---|---|
| ARVINAS, INC. | Comptroller/Controller/Auditor | 07/11/2022 |
Anciens postes connus de David Loomis
| Sociétés | Poste | Fin |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Comptroller/Controller/Auditor | 01/11/2022 |
| BIOHAVEN LTD. | Comptroller/Controller/Auditor | 01/11/2022 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOHAVEN LTD. | Health Technology |
| ARVINAS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
